Conditions: Marginal Ulcers
Keywords: gastric bypass surgery anastomosis, Roux-en-Y Complication, Postoperative
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 40
Healthy volunteers: no

Brief summary:
This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery.

Detailed description:
The purpose of this research is to evaluate information about the control of gastric acid in post gastric bypass surgery patients. Goal is to determine which medication best reduces the incidence of anastomotic ulcers post-operatively.

Arms:
arm 1: 40 mg Omeprazole daily arm 2: 40 mg Famotidine daily

Interventions: intervention 1: Omeprazole intervention 2: Famotidine
Intervention descriptions: intervention 1: 40mg dose administered as a suspension or capsule as physician directs daily at bedtime for 14 weeks beginning day of hospital discharge following gastric bypass surgery. intervention 2: 40mg dose administered as a suspension or capsule as physician directs daily at bedtime for 14 weeks beginning day of hospital discharge following gastric bypass surgery.

Protocol document: